Thus, in prostate cancer, induction of aromatase via ArPII in prostate epithelia results in estrogen synthesis that, in turn, affects the prostate epithelia in an autocrine/intracrine fashion via binding to ER-α. The gene discussed is CYP19A1; the disease is prostate cancer.